West Pharmaceutical Services Inc (WST)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$223.84

Buy

$258.51

arrow-down$-1.99 (-0.77%)

Prices updated at 10 Apr 2026, 12:50 EDT

Prices minimum 15 mins delay

Prices in USD

West Pharmaceutical Services Inc develops, manufactures and sells packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, and prefillable syringe components.

S&P 500

-%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Eric Mark Green

CEO

Mr. Eric Mark Green

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

10,800

Head office

530 Herman O. West Drive

Exton

United States

19341-1147

+1 610 594-2900

John.Sweeney@westpharma.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Eric Mark Green Chief Executive Officer, President and Chairman of the Board	1.18m
Ms. Deborah L.V. Keller Independent Director	0.12m
Mr. Douglas A. Michels Independent Director	0.10m
Mr. Paolo Pucci Lead Independent Director	0.11m
Mr. Robert F. Friel Independent Director	0.13m
Mr. Thomas W. Hofmann Independent Director	0.13m
Ms. Janet Brutschea Haugen Independent Director	0.10m
Mr. Mark A. Buthman Independent Director	0.12m
Dr. Myla P. Lai-Goldman,M.D. Independent Director	0.12m
Dr. William F. Feehery, PhD Independent Director	0.10m
Mr. Norman D. Finch, Jr Senior Vice President, General Counsel and Corporate Secretary	-
Mr. Robert W. McMahon Senior Vice President and Chief Financial Officer	0.29m
Ms. Annette F. Favorite Senior Vice President and Chief Human Resources Officer	0.45m
Ms. Molly E. Joseph Independent Director	0.11m
Mr. Chad R. Winters Vice President, Finance and Chief Accounting Officer	-
Dr. Stephen H. Lockhart, PhD Independent Director	0.10m
Mr. Shane Campbell Chief Proprietary Segment Officer	0.37m
Mr. Rudy J. Poussot Senior Vice President, Strategy and Corporate Development	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	9,539,173
BlackRock Inc	6,455,861
State Street Corp	3,207,911
Bank of New York Mellon Corp	2,904,709
Artisan Partners Limited Partnership	2,850,401

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2025	-
30 Sep 2025	-
11 Aug 2025	-
11 Aug 2025	-
11 Aug 2025	-
11 Aug 2025	-
30 Jun 2025	-
12 May 2025	-
12 May 2025	-
12 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.